Some orthopedic companies have recovered from the pandemic faster than others, as second quarter data shows.
While Stryker and Zimmer's orthopedic sales grew in Q2, Johnson & Johnson's lagged.
Johnson & Johnson reported a 0.7 percent decrease in sales of hip replacements and a 0.1 percent decrease in sales of knee replacements. Zimmer Biomet saw increases of 2.7 percent and 5.9 percent, respectively, and Stryker saw 3.2 and 5.5 percent increases.
Enovis saw an 11 percent increase in net sales, which can be attributed to new acquisitions and product launches, while ZimVie saw an 11.5 percent decrease as its spine and dental sales decreased by 19.6 and 1.8 percent respectively.
Conformis, Orthofix and Surgalign all saw revenue dip in the second quarter, but some were hit harder than others. Suralign saw a 4.2 percent decrease, while Conformis was down 73 percent from last year. Orthofix's net revenue was down 2.7 percent, influenced by a 6.2 percent decrease in spinal implant sales.